Abstract:Abstract Background Accurate variant detection in the coding regions of the human genome is a key requirement for molecular diagnostics of Mendelian disorders. Efficiency of variant discovery from next-generation sequencing (NGS) data depends on multiple factors, including reproducible coverage biases of NGS methods and the performance of read alignment and variant calling software. Although variant caller benchmarks are published constantly, no previous publications have leveraged the full extent of available gold standard whole-genome (WGS) and whole-exome (WES) sequencing datasets. Results In this work, we systematically evaluated the performance of 4 popular short read aligners (Bowtie2, BWA, Isaac, and Novoalign) and 9 novel and well-established variant calling and filtering methods (Clair3, DeepVariant, Octopus, GATK, FreeBayes, and Strelka2) using a set of 14 “gold standard” WES and WGS datasets available from Genome In A Bottle (GIAB) consortium. Additionally, we have indirectly evaluated each pipeline’s performance using a set of 6 non-GIAB samples of African and Russian ethnicity. In our benchmark, Bowtie2 performed significantly worse than other aligners, suggesting it should not be used for medical variant calling. When other aligners were considered, the accuracy of variant discovery mostly depended on the variant caller and not the read aligner. Among the tested variant callers, DeepVariant consistently showed the best performance and the highest robustness. Other actively developed tools, such as Clair3, Octopus, and Strelka2, also performed well, although their efficiency had greater dependence on the quality and type of the input data. We have also compared the consistency of variant calls in GIAB and non-GIAB samples. With few important caveats, best-performing tools have shown little evidence of overfitting. Conclusions The results show surprisingly large differences in the performance of cutting-edge tools even in high confidence regions of the coding genome. This highlights the importance of regular benchmarking of quickly evolving tools and pipelines. We also discuss the need for a more diverse set of gold standard genomes that would include samples of African, Hispanic, or mixed ancestry. Additionally, there is also a need for better variant caller assessment in the repetitive regions of the coding genome.

Hidden Biases in Germline Structural Variant Detection.

Comprehensive Evaluation of Structural Variant Genotyping Methods Based on Long-Read Sequencing Data.

Multi-platform Discovery of Haplotype-Resolved Structural Variation in Human Genomes

Comprehensive and deep evaluation of structural variation detection pipelines with third-generation sequencing data

A Practical Guide for Structural Variation Detection in the Human Genome

A Comparison of Structural Variant Calling from Short-Read and Nanopore-Based Whole-Genome Sequencing Using Optical Genome Mapping as a Benchmark

Tradeoffs in alignment and assembly-based methods for structural variant detection with long-read sequencing data

Mapping and characterization of structural variation in 17,795 deeply sequenced human genomes

Comprehensive evaluation and characterisation of short read general-purpose structural variant calling software

Structural variant calling and clinical interpretation in 6224 unsolved rare disease exomes

Assessing structural variation in a personal genome—towards a human reference diploid genome

Mapping and characterization of structural variation in 17,795 human genomes

Structural variant calling: the long and the short of it

Small polymorphisms are a source of ancestral bias in structural variant breakpoint placement

Mapping Copy Number Variation by Population-Scale Genome Sequencing.

Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies

Systematic benchmark of state-of-the-art variant calling pipelines identifies major factors affecting accuracy of coding sequence variant discovery

Integrative detection and analysis of structural variation in cancer genomes

A benchmarking framework for the accurate and cost-effective detection of clinically-relevant structural variants for cancer target identification and diagnosis

Overview of structural variation calling: Simulation, identification, and visualization

Systematic assessment of structural variant annotation tools for genomic interpretation